Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner

ABSTRACT: Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner

PROVIDER: PRJNA624324 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner.

Project description: Not available

| S-EPMC7415660 | biostudies-literature

Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner

Project description:We report that monocytic (mMDSC) and granulocytic (gMDSC) MDSC susbsets have distinct expression profiles with ~300-1200 genes uniquely expressed on each subset. We further used these genes for pathway annotation. Our findings identified that mMDSC and gMDSC have unique pathway associations that can be targeted via distinct drug candidates.

2020-04-11 | GSE148467 | GEO

Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets

Project description:Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets

| PRJNA851367 | ENA

Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets

Project description:Increased myeloid-derived suppressor cell (MDSC) frequency is associated with worse outcomes and poor therapeutic response in multiple types of cancer. In the glioblastoma (GBM) microenvironment, monocytic (m) MDSCs represent the predominant subset. However, the molecular basis of mMDSC enrichment in the tumor microenvironment compared to granulocytic (g) MDSCs has yet to be determined. Here we performed first broad epigenetic profiling of MDSC subsets to define underlying cell-intrinsic differences in their behavior and found that mMDSCs and gMDSCs display differences in their tumor-accelerating ability, with mMDSCs driving tumor growth in GBM models. Epigenetic assessments revealed enhanced gene accessibility for cell adhesion programs in mMDSCs and higher integrin b1 expression and function in mouse and human mMDSCs. Integrin b1 blockage abrogated the tumor-promoting phenotype of mMDSCs and altered the immune profile in the tumor microenvironment. These findings suggest that integrin b1 expression underlies the enrichment of mMDSCs in tumors and represents a putative immunotherapy target to attenuate myeloid cell-driven immune suppression in GBM.

2022-06-26 | GSE206551 | GEO

Pathologically distinct fibroblast subsets drive inflammation and tissue damage in arthritis

Project description:Pathologically distinct fibroblast subsets drive inflammation and tissue damage in arthritis

| PRJNA530021 | ENA

Pathologically distinct fibroblast subsets drive inflammation and tissue damage in arthritis

Project description:Pathologically distinct fibroblast subsets drive inflammation and tissue damage in arthritis

| PRJNA531402 | ENA

Brd4-bound enhancers drive cell intrinsic sex differences in glioblastoma.

Project description:Brd4-bound enhancers drive cell intrinsic sex differences in glioblastoma.

| PRJNA658688 | ENA

Brd4-bound enhancers drive cell intrinsic sex differences in glioblastoma

Project description:Brd4-bound enhancers drive cell intrinsic sex differences in glioblastoma